|(a) Each facility shall maintain a clinical death review committee which shall be a medical peer review body pursuant to the statutes that authorize peer review activities in the State of Texas. The clinical death review committee shall be responsible for reviewing deaths and the quality of care delivered prior to each death reviewed by that committee. (b) The purpose of the committee is: (1) to review the quality and appropriateness of medical care and other medically related services rendered prior to the death; and (2) to recommend, when appropriate, changes in medically related policy and procedure, professional education, clinical operations, or patient care. (c) The clinical death review committee shall be chaired by a physician and include representatives of the following functions listed, which in some circumstances may be staffed by the same individual, e.g., the clinical/medical director may be the attending physician as well: (1) the clinical/medical director or designee, who shall serve as chair provided that person is not the attending physician (the facility CEO will appoint a replacement chair when the chair of the clinical death review committee is the attending physician); (2) the investigating officer; (3) the director of nursing or registered nurse designee; (4) the attending physician; (5) the director of clinical quality assurance, designee, or the person who is responsible for clinical quality assurance functions; and (6) other medical/nursing professionals as deemed appropriate by the committee chair, e.g., the duty physician at the time of the death, etc. (d) The clinical death review committee shall solicit a physician external to TXMHMR to participate as a member of the clinical death review committee. If such physician is not available, then the effort to obtain external membership must be documented in the information sent to the administrative death review committee. For the purposes of this subchapter, physicians who are consultants or contractors are considered external to TXMHMR.